Recurrent HCC tumor cells interact with cDC2/LAMP3+ DCs via CD274/CD80 and CTLA4/CD80, leading to the formation of clusters around DCs and subsequently reducing antigen presentation and T cell activation efficiency [38]. The gene discussed is CD80; the disease is hepatocellular carcinoma.